An exciting opportunity to become part of a great team! If you are an expert in GMP compliant facility operations and ready to be a leader, check out this job at Vectorbiomed.com
SHIELA SLOTHOWER is #hiring. Know anyone who might be interested?
We help our partners move rapidly from therapeutic concept to clinical development by providing high-quality Lentiviral vector manufacturing solutions and supporting services at extraordinary value.
Vector BioMed, Inc.的外部链接
910 Clopper Road
Suite 200S
US,Maryland,Gaithersburg,20878
An exciting opportunity to become part of a great team! If you are an expert in GMP compliant facility operations and ready to be a leader, check out this job at Vectorbiomed.com
SHIELA SLOTHOWER is #hiring. Know anyone who might be interested?
We are happy to report that Cellular Origins, specializing in cell and gene therapy automation, informed us that they will be joining the G-Rex Grant Program alongside our legion of likeminded collaborators which now includes Wilson Wolf Manufacturing, LLC,?Bio-Techne,?CellReady?,Akadeum Life Sciences, Inc.,?MaxCyte, Inc.,?Vector BioMed, Inc.?and Applied Cells ! Welcome aboard!
We’ve been eager to let you know about the rollout of a $20 million G-Rex Grant Program which goes live today and is accessible to every cell and gene therapy entity that is moving toward, or already conducting, clinical manufacturing. The program goal is to ensure that every recipient is able to establish the most cost effective manufacture of clinical products in the shortest amount of time. To meet that goal, the G-Rex Grant Program includes a wide range of essential products, services, and expertise that will all be made available to recipients. We hope that academic entities and private companies will take advantage of this program. It’s open to all, designed to be very easy to use, and we’re confident that every participant will find it highly beneficial. This program is possible thanks to the participation of forward-thinking collaborators who are dedicated to making a meaningful impact in the field of cell and gene therapy, including Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady?, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. If there are other like-minded entities that have the ability to help propel our goal, please don’t hesitate to reach out to us. We’d also kindly request that people seeing this message repost it so that it reaches the broadest audience possible. You can learn more about how easy it is to become a recipient of a G-Rex Grant here: https://lnkd.in/eWesmsWJ #cellandgenetherapy #GRex #innovation #collaboration
I’m #hiring. Know anyone who might be interested? ????
此处无法显示此内容
在领英 APP 中访问此内容等
Our mission: EVERYONE in the world should be able to afford lifesaving cell and gene therapies. If you share our mission, let's partner and make it a reality! Experience matters when manufacturing pre-clinical & GMP vectors, and when providing regulatory, preclinical, clinical, and commercial support solutions. Our rapid and robust platform creates custom LV vectors, CAR-T vectors, and enables you to manufacture CAR-T therapies at your facility. If you want to know more and stay up to date, follow our Page.
Jill is excited to show the CGT industry why Vector BioMed is the go-to company for custom lentiviral vector manufacturing solutions. Our leadership has over 100 years of collective LVV experience. VBM has the rapid and affordable platform you need to accelerate your breakthrough life-saving therapies! www.vectorbiomed.com
Looking forward to ATW 2025!
Had an amazing time at the ATW in Miami! We loved meeting so many wonderful people at our booth. If we missed you, don't hesitate to reach out with any questions you may have. #vectors #vectordesign #cellandgenetherapy #viralvectors #advancedtherapies
We are looking back with excitement! #ATW2024 Announcing the joint effort to accelerate the build up of decentral cell & gene therapy manufacturing capacity and capabilities around the world with our partners Adva Biotechnology, Arvato, Cellex Cell Professionals, Hitachi, Swissfinity Group, Hypertrust at Phacilitate Advanced Therapies Week 2024 in Miami. Just a few of the many highlights for Tigen’s Dorothea Ledergerber: - Discussing the opportunities and challenges of decentral CGT manufacturing in the US and beyond on the panel with Boro Dropuli? from Caring Cross and Vector BioMed, Inc.. - Introducing the foundation of the Decentralized Manufacturing Consortium (DMC) for Cell & Gene Therapies to the Phacilitate Decentral Working Group. With all founding members joining the stage. - Seeing innovative ideas coming out of the many multidisciplinary conversations with CGT experts from all fields. - Getting tremendous buy-in and support and leaving Miami with great momentum – decentral manufacturing is clearly one of the next big things in CGT. - Do you want to join the movement? Join us – Now! #advancedtherapiesweek #celltherapy #innovation #collaboration #fightcancer #biotech #healthtech
Roundtable: "ask us anything!" Claim Your Spot Today! January 18, 11:30 am – 12:00 pm EST Beyond Compliance: unlocking therapeutic quality excellence Tips, tools and guidance for quality-driven pharmaceutical and biotech companies. January 16 - 18
Our 3-Day Virtual Therapeutics Event, "Beyond Compliance," is fast approaching! We look forward to everyone joining us for this educational 3-day webinar series, co-sponsored by @Qualistery, with tons of insights, tips, and guidance from therapeutic industry leaders and veterans. Join us on January 18th at 12 pm EST | 5 pm GMT with Bennett Klusas Quality Assurance Specialist at Vector BioMed, Inc. and Jason March Senior Quality Specialist, Qualio for "How to build a paperless therapeutic quality management system" for an in-depth webinar that covers: -Why go electronic and how to select an eQMS -Setting up for migration and going live -Executing an eQMS Register for free here -> https://bit.ly/3RNLL1b